Literature DB >> 9060122

Doppler ultrasonography in suspected intrauterine growth retardation: a randomized clinical trial.

S J Nienhuis1, J S Vles, W J Gerver, H J Hoogland.   

Abstract

A randomized clinical trial was performed to test the hypothesis that if suspected intrauterine growth retardation (IUGR) is associated with normal umbilical artery Doppler ultrasound findings, hospitalization can safely be avoided. One hundred and fifty women with singleton pregnancies and suspected IUGR were randomized between an intervention (n = 74) and a control group (n = 76). In the intervention group, clinicians were strongly requested not to hospitalize for suspected IUGR if the Doppler findings were normal. In the control group, the Doppler results were not revealed and the participants received the standard management for suspected IUGR. Endpoints of the trial were: costs in terms of hospitalization, perinatal outcome, neurological development, and postnatal growth. Duration of hospitalization was significantly shorter in the intervention group than in the control group. Contrary to expectations, the hospitalization rate during pregnancy in the intervention group was not below that of the control group. This negative finding was partly due to the admission of patients in the intervention group despite their normal Doppler results. Moreover, the trial might have induced a more critical attitude towards hospitalization in suspected IUGR, decreasing admission in the control group. No clear differences were found in perinatal outcome, neurological development, or postnatal growth. The results suggest that normal umbilical artery Doppler findings in suspected cases of IUGR justify outpatient management.

Entities:  

Mesh:

Year:  1997        PMID: 9060122     DOI: 10.1046/j.1469-0705.1997.09010006.x

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  11 in total

Review 1.  Fetal and umbilical Doppler ultrasound in high-risk pregnancies.

Authors:  Zarko Alfirevic; Tamara Stampalija; Gillian M L Gyte
Journal:  Cochrane Database Syst Rev       Date:  2013-11-12

Review 2.  WITHDRAWN. Doppler ultrasound for fetal assessment in high risk pregnancies.

Authors:  Zarko Alfirevic; James P Neilson
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 3.  Fetal and umbilical Doppler ultrasound in high-risk pregnancies.

Authors:  Zarko Alfirevic; Tamara Stampalija; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2017-06-13

4.  Serial echocardiography in very preterm infants: a pilot randomized trial.

Authors:  Sara B DeMauro; Meryl S Cohen; Sarah J Ratcliffe; Soraya Abbasi; Barbara Schmidt
Journal:  Acta Paediatr       Date:  2013-09-13       Impact factor: 2.299

Review 5.  Utero-placental Doppler ultrasound for improving pregnancy outcome.

Authors:  Tamara Stampalija; Gillian Ml Gyte; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

Review 6.  Fetal and umbilical Doppler ultrasound in high-risk pregnancies.

Authors:  Zarko Alfirevic; Tamara Stampalija; Gillian Ml Gyte
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 7.  Screening and triage of intrauterine growth restriction (IUGR) in general population and high risk pregnancies: a systematic review with a focus on reduction of IUGR related stillbirths.

Authors:  Aamer Imdad; Mohammad Yawar Yakoob; Saad Siddiqui; Zulfiqar Ahmed Bhutta
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

8.  Umbilical artery Doppler study as a predictive marker of perinatal outcome in preterm small for gestational age infants.

Authors:  Young Ji Byun; Haeng-Soo Kim; Jeong In Yang; Joon Hyung Kim; Ho Yeon Kim; Suk Joon Chang
Journal:  Yonsei Med J       Date:  2009-02-24       Impact factor: 2.759

9.  Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015/080, October 2016).

Authors:  Sven Kehl; Jörg Dötsch; Kurt Hecher; Dietmar Schlembach; Dagmar Schmitz; Holger Stepan; Ulrich Gembruch
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-11-27       Impact factor: 2.915

10.  Bemiparin as a Prophylaxis After an Unexplained Stillbirth: Open-Label Interventional Prospective Study.

Authors:  Ariana Khalis Jawad; Shahla Kareem Alalaf; Mahabad Salih Ali; AbdulKader Ahmad Bawadikji
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.